Treg Directed Therapy for Autoimmune Disorders Summit 2018

Evvnt Promotion / evvnt
Archivio
-
22.05.2018 - 24.05.2018  Westin Boston Waterfront, 425 Summer Street, 02210 Boston, USA
8:00 am to 4:00 pm
 
Temi della conferenza
This is your first and only opportunity to listen to the most advanced clinical case studies from Nektar Therapeutics and Amgen which explore the use of IL-2 to enhance the expansion and activation of the Treg cells. Delve deeper with expert insights from Roche and ILTOO Pharma to understand how IL-2 at low doses could selectively stimulate Treg cells.
URLs: Brochure:https://go.evvnt.com/197029-1?pid=4832
Inquiries: https://go.evvnt.com/197029-2?pid=4832
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Chris Haqq, Kevin Gorski, Nadia Tchao, David Wraith, Andrew Scharenberg, Simrit Parmar, Robert Plenge, Stephen Miller, Todd Brusko, Jeremie Mariau, Laurence Turka, Jason Fontenot, Leonard Dragone
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/197029-0?pid=4832
Ms. Georgina FitzGerald
 
Categorie
Medicina interna
Lingua
Inglese
Quote del Congresso
USD 499,00
(Conference Only (Earlybird ends Feb 23): USD 1999, Conference Only (Earlybird ends Mar 23): USD 2199,Conference Only: USD 2799,Workshop Only: USD 499)
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Center of ExcellenceÖsterreichische Gesellschaft für Public HealthCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAnästhesie in Entwicklungsländern e. V.Österreichische Akademie der ÄrzteSwiss Tropical and Public Health InstituteOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation AGEM - Arbeitsgemeinschaft Ethnologie und Medizin